Octagon Capital Advisors

Octagon Capital Advisors as of March 31, 2025

Portfolio Holdings for Octagon Capital Advisors

Octagon Capital Advisors holds 34 positions in its portfolio as reported in the March 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Nuvation Bio *w Exp 02/10/202 (NUVB.WS) 9.3 $48M 27M 1.76
Apellis Pharmaceuticals (APLS) 8.9 $46M 2.1M 21.87
Dianthus Therapeutics (DNTH) 8.2 $43M 2.3M 18.14
Arrivent Biopharma (AVBP) 7.4 $38M 2.1M 18.49
Centessa Pharmaceuticals Sponsored Ads Put Option (CNTA) 5.6 $29M 2.0M 14.38
Trevi Therapeutics (TRVI) 4.0 $21M 3.3M 6.29
Gossamer Bio (GOSS) 3.9 $20M 18M 1.10
Ocular Therapeutix (OCUL) 3.4 $18M 2.4M 7.33
Mind Medicine Mindmed Com New (MNMD) 3.4 $18M 3.0M 5.85
Cogent Biosciences (COGT) 3.2 $17M 2.8M 5.99
Kalvista Pharmaceuticals (KALV) 3.1 $16M 1.4M 11.54
Taysha Gene Therapies Com Shs (TSHA) 2.9 $15M 11M 1.39
Nuvation Bio Com Cl A (NUVB) 2.7 $14M 7.9M 1.76
Verona Pharma Sponsored Ads (VRNA) 2.7 $14M 217k 63.49
Tourmaline Bio (TRML) 2.7 $14M 905k 15.21
Merus N V (MRUS) 2.5 $13M 308k 42.09
Pharvaris N V (PHVS) 2.3 $12M 770k 15.70
Moonlake Immunotherapeutics Class A Ord (MLTX) 2.2 $12M 296k 39.07
Syndax Pharmaceuticals (SNDX) 2.1 $11M 904k 12.29
Atyr Pharma Com New (ATYR) 2.1 $11M 3.6M 3.02
Scholar Rock Hldg Corp (SRRK) 2.0 $11M 329k 32.15
Verastem Com New (VSTM) 2.0 $10M 1.7M 6.03
Regulus Therapeutics 1.6 $8.1M 4.6M 1.75
Silverback Therapeutics (SPRY) 1.5 $7.9M 625k 12.58
Abivax Sa Sponsored Ads (ABVX) 1.5 $7.7M 1.2M 6.25
Erasca (ERAS) 1.4 $7.0M 5.1M 1.37
Miragen Therapeutics (VRDN) 1.2 $6.1M 450k 13.48
Corbus Pharmaceuticals Hldgs Com New (CRBP) 1.1 $5.9M 1.1M 5.31
Unicycive Therapeutics 1.1 $5.7M 10M 0.57
Maze Therapeatics (MAZE) 1.0 $5.2M 468k 11.01
Perspective Therapeutics Com New (CATX) 0.9 $4.8M 2.3M 2.13
Kalaris Therapeutics (KLRS) 0.7 $3.9M 481k 8.03
Neurogene (NGNE) 0.7 $3.5M 303k 11.71
Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) 0.5 $2.8M 250k 11.30